MedTrace Logo

Endoscopic Mini/Less Open Sublay(EMILOS) Repair

NCT05912868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2023-06-22

No results posted yet for this study

Summary

Ventral hernias in the midline of the abdominal wall are one of the most frequent diseases in general and visceral surgery worldwide. The optimal operative technique is still in discussion. The traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Conditions

  • Hernia, Ventral

Interventions

DEVICE

Endoscopic Mini/Less Open Sublay Repair

The traditional techniques are open sublay or transabdominal intraperitoneal onlay mesh (IPOM) repair. In order to avoid the risks -large trauma to the abdominal wall with pain and infection, lesion of intraabdominal organs - a new hybrid technique - small skin incision, wide endoscopic dissection of the retrorectus space with implantation of a large mesh - was developed (EMILOS -Endoscopic Mini/Less Open Sublay).

Sponsors & Collaborators

  • Diakonie-Klinikum Stuttgart

    lead OTHER

Principal Investigators

  • Prof. Dr. med. Dr.h.c. Bittner · unaffiliated, retirement

  • Dr. Bärbel Kraft · Diakonie-Klinikum Stuttgart

  • Dr. Jochen Schwarz · Hernienzentrum Rottenburg

  • Dr.Stefan Amann · Diakoneo Klinik Neudettelsau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-25
Primary Completion
2021-01-27
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05912868 on ClinicalTrials.gov